Testing effectiveness (Phase 2)Study completedNCT00819585
What this trial is testing
The Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)
Who this might be right for
Gout
Novartis Pharmaceuticals 432